We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current IMU market cap is 611.08M. The company's latest EPS is AUD -0.0052 and P/E is -15.38.
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 4.13M | 4.21M | 7.28M | 12.97M | 11.78M |
| Operating Income | -8.26M | -10.67M | -18.39M | -37.7M | -39.52M |
| Net Income | -7.78M | -10.51M | -18.46M | -37.87M | -37.92M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 30.78M | 65.21M | 71.81M | 147.61M | 197.06M |
| Total Liabilities | 3.48M | 5.4M | 6.79M | 8.9M | 7.44M |
| Total Equity | 27.3M | 59.81M | 65.02M | 138.71M | 189.63M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -7.91M | -10.44M | -13.28M | -30.85M | -31.47M |
| Investing | 247k | -1.21M | -5.33M | -221k | 1.7M |
| Financing | 18.77M | 22.71M | 17.99M | 101.34M | 82.98M |
| Market Cap | 611.08M |
| Price to Earnings Ratio | -15.38 |
| Price to Sales Ratio | 50 |
| Price to Cash Ratio | 3.83 |
| Price to Book Ratio | 3.09 |
| Dividend Yield | - |
| Shares Outstanding | 7.32B |
| Average Volume (1 week) | 46.93M |
| Average Volume (1 Month) | 23.2M |
| 52 Week Change | -38.15% |
| 52 Week High | 0.15 |
| 52 Week Low | 0.039 |
| Spread (Intraday) | 0 (1.19%) |
| Company Name | Imugene Limited |
| Address |
level 3 melbourne, victoria 3053 |
| Website | https://www.imugene.com |
| Industry | biotechnology animal & plant (C36) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
